"Memorial Sloan Kettering Westchester allows patients who reside in the Hudson Valley area to receive state-of-the-art care closer to home. For general information, call Memorial Sloan Kettering at 212-639-2000, 24 hours a day, seven days a week. To make an appointment, call us at 833-494-2758, Monday through Friday between 8:00 AM and 6:00 PM ET."

During the past decade, Memorial Sloan Kettering Westchester conducted 490 clinical trials. In the 10-year time frame, 490 clinical trials started and 69 clinical trials were completed, i.e. on average, 14.1% percent of trials that started reached the finish line to date. In the past 5 years, 221 clinical trials started and 63 clinical trials were completed. i.e. 28.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Memorial Sloan Kettering Westchester" #1 sponsor was "Memorial Sloan Kettering Cancer Center" with 425 trials, followed by "National Cancer Institute (NCI)" with 53 trials sponsored, "NRG Oncology" with 18 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored and "Pfizer" with 15 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Memorial Sloan Kettering Westchester" #1 collaborator was "National Cancer Institute (NCI)" with 54 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "Bristol-Myers Squibb" with 15 trials as a collaborator, "Genentech, Inc." with 15 trials as a collaborator and "Merck Sharp & Dohme LLC" with 15 trials as a collaborator. Other collaborators include 464 different institutions and companies that were collaborators in the rest 263 trials.

According to Clinical.Site data, the most researched conditions in "Memorial Sloan Kettering Westchester" are "Breast Cancer" (56 trials), "Prostate Cancer" (27 trials), "Multiple Myeloma" (21 trials), "Lung Cancer" (19 trials) and "Ovarian Cancer" (15 trials). Many other conditions were trialed in "Memorial Sloan Kettering Westchester" in a lesser frequency.

Most popular intervention types in "Memorial Sloan Kettering Westchester" are "Drug" (384 trials), "Other" (135 trials), "Radiation" (118 trials), "Procedure" (97 trials) and "Behavioral" (61 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (34 trials), "Quality-of-Life Assessment" (34 trials), "Pembrolizumab" (29 trials), "Cisplatin" (27 trials) and "Computed Tomography" (25 trials). Other intervention names were less common.

The vast majority of trials in "Memorial Sloan Kettering Westchester" are 444 trials for "All" genders, 102 trials for "Female" genders and 31 trials for "Male" genders.

Currently, there are NaN active trials in "Memorial Sloan Kettering Westchester". undefined are not yet recruiting, 233 are recruiting, 224 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 95 completed trials in Memorial Sloan Kettering Westchester, 2 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Memorial Sloan Kettering Westchester, 116 "Phase 1" clinical trials were conducted, 282 "Phase 2" clinical trials and 92 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 49 trials that are defined as “Not Applicable".